查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392037

鱼皮肤病市场：按类型、按治疗类型、按给药途径、按配销通路、按地区

Fish Skin Disease Market, By Type (Ichthyosis vulgaris, X-linked recessive ichthyosis, Others ), By Treatment type (Corticosteroids, Emollients, Retinoids, Others ), By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球鱼皮病市场价值为14亿美元，预计将以9.8%的复合年增长率成长，到年终达到27亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 14亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 9.80% 2030年市场规模预测 27亿美元
图 1. 2023 年按地区分類的鱼皮肤病全球市场占有率(%)
鱼皮症市场-IMG1

鱼皮病是一种导致大面积持续存在厚厚、干燥、「鱼鳞」状皮肤的疾病。鱼皮病是一种皮肤病，会导致皮肤干燥、发痒、鳞状、粗糙、发红。症状从轻微到严重不等。鱼皮肤病可能只影响皮肤，但有些也可能影响内臟。鱼类皮肤病有20多种。有些类型是出生时遗传的，而有些则是成年后获得的。治疗有助于减少皮肤发红、鳞屑厚度和搔痒。

市场动态：

鱼皮肤病负担的增加、公众意识的提高、对安全有效的治疗方法方法的需求不断增加，以及市场参与企业推出新的治疗方法和疗法，正在推动全球鱼皮肤病市场的成长。推动

例如，2023年4月，鱼皮治疗产品製造商Kerecis宣布推出MariGen Shield，这是一种将其鱼皮移植物与硅胶接触层相结合的解决方案，用于治疗慢性和复杂的伤口。 。硅胶接触层有助于将圆形移植物固定指定并保护肉芽伤口。

此外，2021 年 10 月，Kelesis 获得了美国食品药物管理局(FDA) 的 Omega3 SurgiBind 行销核准。这是一种可植入的鱼皮移植物，用于整形和重组手术。它在整形和重组手术中用于强化需要软组织修復或加固的患者的软组织。

本研究的主要特点

  • 本报告对全球鱼皮病市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-20230）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、业绩和策略）介绍了全球鱼皮病市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球鱼皮病市场的各种策略矩阵来促进他们的决策。

目录：

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 世界各地鱼类皮肤病的负担不断增加
    • 缺乏人力资源意识
    • 安全有效治疗方法的需求增加
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章鱼皮肤病市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章鱼皮肤病市场，依类型，2018-2030

  • 介绍
  • 鱼类寻常性皮肤病
  • X连锁隐性鱼皮肤病
  • 其他（体染色体隐性遗传先天性鱼皮肤病等）

第六章鱼皮肤病市场，依治疗类型，2018-2030

  • 介绍
  • 皮质类固醇
  • 润肤剂
  • 类视色素A
  • 其他（角质层分离剂等）

第 7 章 鱼皮症市场，依给药途径，2018-2030 年

  • 介绍
  • 局部的
  • 口服
  • 胃肠外的

第8章鱼皮病市场，依配销通路划分，2018-2030

  • 介绍
  • 医院药房
  • 零售药房
  • 线上药房

第9章 2018-2030年鱼皮病市场（按地区）

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 印度
  • 中国
  • 日本
  • 澳洲
  • 东南亚国协
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • GSK Plc.
  • AbbVie Inc.
  • Sonnet BioTherapeutics
  • Krystal Biotech
  • LEO Pharma
  • GALDERMA
  • GLENMARK PHARMACEUTICALS LTD.
  • Mayne Pharma Group Limited
  • Ortho Dermatologics
  • Cellegy Pharmaceuticals
  • Patagonia Pharmaceuticals, LLC
  • Crown Laboratories, Inc.

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5696

The Global Fish Skin Disease Market, was valued at US$ 1.4 Billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% to reach US$ 2.7 Billion by end of 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.80% 2030 Value Projection: US$ 2.7 Bn
Figure 1. Global Fish Skin Disease Market Share (%), By Region, 2023
Fish Skin Disease Market - IMG1

Ichthyosis is a medical condition that causes widespread and persistent thick, dry, "fish-scale" skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at birth, and others are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.

Market Dynamics:

The rise in burden of fish skin disease, the rise in awareness among people, the increase in demand for safe, effective treatments & therapies, and the introduction of novel treatments and therapies by market players are major factors expected to propel growth of the global fish skin disease market.

For instance, in April 2023, Kerecis, a manufacturer of fish skin-based therapeutic products announced the launch of the MariGen Shield, a solution that combines the company's fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position and help safeguard granulating wound

Moreover, in October 2021, Kerecis received the U.S. Food and Drug Administration (FDA) marketing authorization for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair or reinforcement in plastic or reconstructive surgery.

Key features of the study:

  • This report provides in-depth analysis of the global fish skin disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-20230), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market

Fish Skin Disease Market Detailed Segmentation:

  • By Type:
    • Ichthyosis vulgaris
    • X-linked recessive ichthyosis
    • Others (Autosomal recessive congenital ichthyosis, etc.)
  • By Treatment Type:
    • Corticosteroids
    • Emollients
    • Retinoids
    • Others (Keratolytics, etc.)
  • By Route of Administration:
    • Topical
    • Oral
    • Parenteral
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • GSK Plc.
    • AbbVie Inc.
    • Sonnet BioTherapeutics
    • Krystal Biotech
    • LEO Pharma
    • GALDERMA
    • GLENMARK PHARMACEUTICALS LTD.
    • Mayne Pharma Group Limited
    • Ortho Dermatologics
    • Cellegy Pharmaceuticals
    • Patagonia Pharmaceuticals, LLC
    • Crown Laboratories, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Fish Skin Disease, By Type
    • Market Fish Skin Disease, By Treatment Type
    • Market Fish Skin Disease, By Route of Administration
    • Market Fish Skin Disease, By Distribution Channel
    • Market Fish Skin Disease, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of fish skin disease across the globe
    • Lack of awareness among people
    • Increase in demand for safe and effective treatments/therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Fish Skin Disease Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fish Skin Disease Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Ichthyosis vulgaris
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • X-linked recessive ichthyosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Others (Autosomal recessive congenital ichthyosis, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)

6. Fish Skin Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Emollients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Retinoids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)
  • Others (Keratolytics, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030,(US$ Bn)

7. Fish Skin Disease Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Fish Skin Disease Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Fish Skin Disease Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • India
  • China
  • Japan
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • GSK Plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
  • Sonnet BioTherapeutics
  • Krystal Biotech
  • LEO Pharma
  • GALDERMA
  • GLENMARK PHARMACEUTICALS LTD.
  • Mayne Pharma Group Limited
  • Ortho Dermatologics
  • Cellegy Pharmaceuticals
  • Patagonia Pharmaceuticals, LLC
  • Crown Laboratories, Inc.
  • Analyst Views

11. Section

  • Research Methodology
  • About us